Prior Investments

BardyDX Logo

BardyDX

Dr. Gust Bardy founded BardyDX in 2013 to overcome common challenges in ambulatory cardiac monitoring. The company has developed the Carnation Ambulatory Monitor (CAM), a lightweight ECG patch monitor with a lightweight, easy to wear device with a focus on measuring the P-wave. The additional clarity in ECG readings allow physicians to gather more information about the heart rhythm to use in clinical diagnoses.


Gauss Logo

Gauss Surgical

Gauss Surgical is a leading company in maternal health. Their innovative Triton platform enables physician to utilize AI-powered technology for real time monitoring of surgical blood loss. The applications for obstetric blood loss monitoring in both the operating room and labor room has helped the industry shift from Estimated Blood Loss into Quantified Blood Loss.

Acquired by Stryker.


Phynd Logo

Phynd

Phynd Technologies is a privately held, venture-funded company focused on solving the health care provider data management problem. Founded in 2012, Phynd enables health care organizations to improve financial results and clinical outcomes, while reducing the risk by securely gathering, managing, and sharing mission-critical provider data.Phynd Technologies is a privately held, venture-funded company focused on solving the health care provider data management problem. Founded in 2012, Phynd enables health care organizations to improve financial results and clinical outcomes, while reducing the risk by securely gathering, managing, and sharing mission-critical provider data.

Acquired by symplr.


Target

Target PharmaSolutions

Inspired by the success of HCV-TARGET, a case study of the TARGET model in hepatitis C, TARGET PharmaSolutions was formed in February 2015. Target PharmaSolutions is a clinical data company that provides pharmaceutical partners a more efficient way to generate data that can be used to better understand the natural history of diseases, including treatment outcomes in the real world setting.

“Working with Rex Health Ventures has been a tremendous asset to TARGET PharmaSolutions. As our lead investor, they have provided critical strategic guidance and financial support that has enabled us to quickly scale.” – TARGET PharmaSolutions CEO Meg Powell

Acquired by Norwest Venture Partners.


Veran

Veran Medical Technologies

Veran is a privately-held medical device company headquartered in St. Louis, MO. The company’s main focus is assisting physicians in the early diagnosis and treatment of lung cancer. Veran’s breakthrough technology has been adopted by leading cancer centers throughout the United States.

Acquired by Olympus in 2020.


Midnight Pharma

Midnight Pharma LLC is an early stage biopharmaceutical development company that is developing a novel product for the treatment of insomnia. Midnight is privately-held, and was founded in 2015 by the management team from Aerial BioPharma, Addrenex Pharmaceuticals and Neuronex, all founded in the RTP region of North Carolina.

Asset licensed


Awarepoint Logo

Awarepoint

Founded in 2002, Awarepoint leads the innovation of real-time location systems (RTLS) and the practical applications of location as a service. The company’s integrated solutions and patented technologies, based on Bluetooth Low Energy (BLE) and Wi-Fi, simplify the implementation of proven RTLS applications across the Internet of Things (IoT) continuum, enabling clients to rapidly achieve unprecedented benefits and rapid return on investment.

Assets acquired by Centrak in 2018.


Aerial BioPharma Logo

Aerial BioPharma

Aerial BioPharma is a development stage biopharmaceutical company focused on developing biologics and small molecules for conditions in the central nervous system. Aerial is a privately held company, founded in January 2011 by the management team from Addrenex Pharmaceuticals and Neuronex, two successful startup companies founded in the RTP region of North Carolina. In 2014, Jazz Pharmaceuticals acquired Aerial’s primary compound in clinical development for the treatment of excessive daytime sleepiness in patients with narcolepsy.

Assets acquired by Jazz Pharmaceutical in 2014.